| Catalog No | Product Description | CAS No. | Purity | Structural Formula |
|---|---|---|---|---|
| BP1072 |
Peimine
Peimine has good anti-inflammatory effects in vivo, it inhibits the production of inflammatory cytokines induced by LPS through blocking MAPKs and NF-κB signaling pathways. It also has antitussive and sedative actions, the action being suspected to be central in nature.
|
23496-41-5 | 98% |
|
| BP2135 |
Flavanomarein
Flavanomarein demonstrates potent antioxidative property, including free radical scavenging activity, inhibition of lipid peroxidation, as well as lipid‑lowering effects in human HepG2 hepatocellular carcinoma cells treated with free fatty acids (FFAs).
|
577-38-8 | 98% |
|
| BP1492 |
Pteryxin
(+)-Pteryxin has muscle-relaxant props, it also shows hepatoprotective and nitric oxide prodn. inhibitory activity.
|
13161-75-6 | 98% |
|
| BP5160 | 41263-94-9 | 98% |
|
|
| BP2327 | 4712-12-3 | 98% |
|
|
| BP1615 | 520-11-6 | 98% |
|
|
| BP5163 | 157574-76-0 | 98% |
|
|
| BP5161 |
3-Fucosyllactose
3-fucosyllactose is a trisaccharide that is lactose in which the hydroxy group at position 3 of the glucosyl moiety has undergone formal condensation with the anomeric hydroxy group of fucose (6-deoxy-L-galactose) to give the corresponding glycoside. Found in human milk. It has a role as a human metabolite. It is functionally related to a lactose.
|
41312-47-4 | 99% |
|
| BP5474 |
Lacto-N-triaose
Lacto-N-triaose is an oligosaccharide.
|
75645-27-1 | 98% |
|
| BP5436 | 13007-32-4 | 98% |
|
|
| BP5475 |
Lacto-N-tetraose
Beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc is a tetrasaccharide comprising residues of galactose, N-acetylglucosamine, galactose and glucose in a linear sequence, all joined by beta-linkages. It is a glucosamine oligosaccharide and an amino tetrasaccharide.
|
14116-68-8 | 98% |
|
| BP0033 |
Inulicin
Inulicin is a terpene lactone.
|
33627-41-7 | 98% |
|
| BP5196 |
Avenanthramide E
Avenanthramide E is an alkaloid and a member of benzamides.
|
93755-77-2 | 98% |
|
| BP1067 |
Patchouli alcohol
Patchouli alcohol has anti-inflammatory, neuroprotective, anti-cancer, anti-oxidant, gastroprotective, immunomodulatory, and antibacterial effects, which may be mediated, at least in part, by down-regulation of the mRNA expression of a panel of inflammatory mediators, such as TNF-α, IL-1β, IL-6, iNOS and COX-2. Patchouli alcohol significantly accelerates the recovery of the UV-induced skin lesions, evidently through anti-oxidant and anti-inflammatory action, as well as down-regulation of the MMP-1 and MMP-3 expression. Patchouli alcohol is a carbotricyclic compound and sesquiterpenoid tertiary alcohol that is tricyclo[5.3.1.03,8]undecan-3-ol which is substituted at positions 2, 2, 6 and 8 by methyl groups (the 1R,3R,6S,7S,8S-diastereoisomer). It is a sesquiterpenoid, a tertiary alcohol and a carbotricyclic compound.
|
5986-55-0 | 98% |
|
| BP4390 |
3',4',7-Trimethoxyquercetin
Quercetin 7,3',4'-trimethyl ether is a trimethoxyflavone that is the 7,3',4'-trimethyl ether derivative of quercetin. It has been isolated from Euodia confusa. It has a role as a metabolite and a plant metabolite. It is a member of 3'-methoxyflavones, a trimethoxyflavone, a member of flavonols and a dihydroxyflavone. It is functionally related to a quercetin.
|
6068-80-0 | 98% |
|
| BP0682 |
Glycyrrhizic acid
Glycyrrhizic acid has anti-tumor, antiviral ,antiallergic, anti-inflammatory, immunoregulatory,anti-diabetic activities. It is a direct HMGB1(high mobility group box 1) inhibitor that inhibits HMGB1-dependent inflammatory molecule expression and oxidative stress; modulates P38 and P-JNK but not p-ERK signalling; Also inhibits 11 beta-hydroxysteroid dehydrogenase and monoamine oxidase (MAO). Glycyrrhizinic acid is a triterpenoid saponin that is the glucosiduronide derivative of 3beta-hydroxy-11-oxoolean-12-en-30-oic acid. It has a role as an EC 3.4.21.5 (thrombin) inhibitor and a plant metabolite. It is a glucosiduronic acid, a pentacyclic triterpenoid, a tricarboxylic acid, an enone and a triterpenoid saponin. It is a conjugate acid of a glycyrrhizinate(3-).
|
1405-86-3 | 98%/90% |
|
| BP3251 |
Melittoside
Melittoside is a glycoside and an iridoid monoterpenoid.
|
19467-03-9 | 98% |
|
| BP1555 |
Mogroside IIIe
Mogroside IIIe has anti-inflammatory activity, it attenuates LPS-induced acute lung injury in mice partly through regulation of the TLR4/MAPK/NF-κB axis via AMPK activation. It also has anti-fibrotic activity, it reduces pulmonary fibrosis through Toll-Like receptor 4 pathways. Mogroside IIIE is a mogroside, a beta-D-glucoside and a disaccharide derivative. It has a role as an antifibrotic agent and a plant metabolite. It is functionally related to a mogroside IE.
|
88901-37-5 | 98% |
|
| BP1073 |
Peiminine
Peiminine has potent anti-inflammatory, anti-allergic, antitussive, and expectorant effects. It induces autophagic cell death thus represses colorectal carcinoma tumor growth. Peiminine can inhibit lung inflammation and pulmonary fibrosis in a rat model of bleomycin-induced lung injury, by reducing circulating IFN-γ levels and inhibiting signal transduction pathways involving TGF-β, CTGF, ERK1/2, NF-κB and FasL.
|
18059-10-4 | 98% |
|
| BP0583 |
Fargesin
Fargesin has anti-inflammatory, anti-cancer, antihypertensive , and anti-bone-resorbing effects, it is widely used in the treatment of managing rhinitis, inflammation, histamine, sinusitis, and headache. Fargesin improves lipid and glucose metabolism in 3T3-L1 adipocytes and high-fat diet-induced obese mice by activating Akt and AMPK in WAT. It as a potential β1 adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis.
|
31008-19-2 | 98% |
|
Shenshuai
Wenjing
Hedandan